Surge

Surge (also known as surge2surgery) is a biotech company developing AI-based software that predicts the risk of post-operation complications. Its product uses machine learning algorithms to decode a patient's immune system from a blood sample providing an assessment of each individual’s risk of developing a postoperative infection.